secretome Therapeutics is developing a pipeline of secretome products to address diseases driven by inflammation and mitochondrial dysfunction.
Location: United States, Maryland, Baltimore
Employees: 1-10
Total raised: $27.3M
Founded date: 2018
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.11.2024 | - | $20.4M | - |
| 01.02.2023 | - | $6.9M | - |
Mentions in press and media 2
| Date | Title | Description |
| 25.11.2024 | Secretome Therapeutics Raises $20.4M in Financing | Secretome Therapeutics, a Dallas, TX-based biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), raised $20.4M in funding. Backers were not disclosed. The company intends to use the funds to suppo... |
| - | Secretome Therapeutics | “Secretome” |